Systemic delivery of tenofovir alafenamide using dissolving and implantable microneedle patches

The human immunodeficiency virus (HIV) remains a global health concern, with 37.7 million people currently living with the infection and 1.5 million new cases every year. Current antiretroviral (ARV) therapies are administered through the oral route daily, often in lifelong treatments, leading to pi...

Descripción completa

Detalles Bibliográficos
Autores principales: Paredes, Alejandro J., Volpe-Zanutto, Fabiana, Vora, Lalitkumar K., Tekko, Ismaiel A., Permana, Andi Dian, Picco, Camila J., McCarthy, Helen O., Donnelly, Ryan F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Full Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858997/
https://www.ncbi.nlm.nih.gov/pubmed/35243292
http://dx.doi.org/10.1016/j.mtbio.2022.100217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858997/
https://www.ncbi.nlm.nih.gov/pubmed/35243292
http://dx.doi.org/10.1016/j.mtbio.2022.100217

Ejemplares similares